Experienced in Neuroendocrine Carcinoma of the Cervix

Michael F. Milosevic

Toronto, ON, CA 
Experienced in Neuroendocrine Carcinoma of the Cervix
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Michael Milosevic practices in Toronto, Canada. Mr. Milosevic is rated as an Experienced expert by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. His top areas of expertise are Cervical Cancer, Cerebral Hypoxia, Delayed Growth, Cystectomy, and Prostatectomy.

His clinical research consists of co-authoring 149 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Neuroendocrine Carcinoma of the Cervix.

Gender
Male

Locations

Toronto, ON, Canada
Other Locations
Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Feasibility Study of Hypoxia Imaging in Patients With Cervix Cancer Using Positron Emission Tomography (PET) With 18F-Fluoroazomycin Arabinoside (18F-FAZA)
A Feasibility Study of Hypoxia Imaging in Patients With Cervix Cancer Using Positron Emission Tomography (PET) With 18F-Fluoroazomycin Arabinoside (18F-FAZA)
Enrollment Status: Active_not_recruiting
Publish Date: June 18, 2024
Intervention Type: Procedure
Study Drug: 18F-Fluoroazomycin Arabinoside
Study Phase: Not Applicable
A Pilot Prospective Study of the Utility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI), Diffusion Weighted MRI (DWI)and Positron Emission Tomography (PET) Imaging With 18F-Fluorodeoxyglucose (18FDG) in Brachytherapy for Cervix Cancer
A Pilot Prospective Study of the Utility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI), Diffusion Weighted MRI (DWI)and Positron Emission Tomography (PET) Imaging With 18F-Fluorodeoxyglucose (18FDG) in Brachytherapy for Cervix Cancer
Enrollment Status: Completed
Publish Date: November 08, 2022
Intervention Type: Biological
Study Drug: 18F-Fludeoxyglucose
Study Phase: Not Applicable
View 1 Less Clinical Trial

148 Total Publications

Clinical outcomes of neuroendocrine carcinoma of the cervix: Retrospective review from a large academic cancer centre.
Clinical outcomes of neuroendocrine carcinoma of the cervix: Retrospective review from a large academic cancer centre.
Journal: Gynecologic oncology reports
Published: June 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Milosevic's expertise for a condition
ConditionClose
View All 11 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile